Clinical Trial: Clinical efficacy of Shuanghuanglian mixture combined with hyperbaric oxygen therapy in the treatment of Mycoplasma pneumoniae pneumonia and its intervention effect on inflammatory-immune function (China)

Posted On: 2026-11-02

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy of Shuanghuanglian mixture combined with hyperbaric oxygen therapy in the treatment of Mycoplasma pneumoniae pneumonia and its intervention effect on inflammatory-immune function'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135655

Registration Time: 2026/11/01

Type: Interventional study

Primary Sponsor: Shanghai Fifth Peoople's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=309063

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical efficacy of Shuanghuanglian mixture combined with hyperbaric oxygen therapy in the treatment of Mycoplasma pneumoniae pneumonia and its intervention effect on inflammatory-immune function (China)